CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...

DNA commodification is no longer a future concern; it’s a present reality. Beyond charging users for their services, some ...

The company is scheduled to hold its third quarter 2024 earnings conference call after the market closes on Thursday November 7, 2024, and intends to provide additional information regarding its ...

Facebook’s business model revolves around sharing information with many third parties. Unlike medical providers, genetic testing companies aren’t bound by health privacy laws such as HIPAA despite the ...

Highlights Third quarter revenue grew 11% year-over-year to $213 million, driven by Pharmacogenomics (34%) and Prenatal (10%) ...

Natera's strong financial performance and diversification into multiple segments support a positive outlook. Read why I rate ...

Following the resignation of every independent member of the company’s board of directors, its chief executive, Anne Wojcicki, expressed openness to selling the company and its database of around 15 ...

The chemotherapy drugs 5-FU and capecitabine could harm or kill you if you have a variant in the DPYD gene. Request genetic testing before you take these drugs.

Genetic testing can help identify inherited gene mutations ... Don’t treat it as a substitute for qualified medical opinion. Always consult a specialist for specific health diagnosis.

--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today ...

Adam Brufsky, MD, PhD, professor of medicine at the University of Pittsburgh School of Medicine; Megan Kruse, MD, breast medical oncologist at Cleveland Clinic; and Ruta Rao, MD, professor of medicine ...